Company: TBPH
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-110382
Chunk: 3

Company: Theravance Biopharma, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 230 shares authorized, no shares issued or outstanding​  —​​ —Ordinary shares, $0.00001 par value per share: 200,000 shares authorized; 50,672 and 49,471 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively​  1​​ —Additional paid-in capital​  1,153,299​​ 1,141,060Accumulated other comprehensive income​  32​  7Accumulated deficit ​  (920,651)​  (965,522)Total shareholders’ equity​  232,681​  175,545Total liabilities and shareholders’ equity​$ 415,460​$ 354,161

​

​

See accompanying notes to condensed consolidated financial statements.

​